MitomiRs: their roles in mitochondria and importance in cancer cell metabolism

Abstract

Background MicroRNAs (miRNAs) are short non-coding RNAs that play important roles in almost all biological pathways. They regulate post-transcriptional gene expression by binding to the 3’untranslated region (3’UTR) of messenger RNAs (mRNAs). MitomiRs are miRNAs of nuclear or mitochondrial origin that are localized in mitochondria and have a crucial role in regulation of mitochondrial function and metabolism. In eukaryotes, mitochondria are the major sites of oxidative metabolism of sugars, lipids, amino acids, and other bio-macromolecules. They are also the main sites of adenosine triphosphate (ATP) production. Conclusions In the review, we discuss the role of mitomiRs in mitochondria and introduce currently well studied mitomiRs, their target genes and functions. We also discuss their role in cancer initiation and progression through the regulation of mRNA expression in mitochondria. MitomiRs directly target key molecules such as transporters or enzymes in cell metabolism and regulate several oncogenic signaling pathways. They also play an important role in the Warburg effect, which is vital for cancer cells to maintain their proliferative potential. In addition, we discuss how they indirectly upregulate hexokinase 2 (HK2), an enzyme involved in glucose phosphorylation, and thus may affect energy metabolism in breast cancer cells. In tumor tissues such as breast cancer and head and neck tumors, the expression of one of the mitomiRs (miR-210) correlates with hypoxia gene signatures, suggesting a direct link between mitomiR expression and hypoxia in cancer. The miR-17/92 cluster has been shown to act as a key factor in metabolic reprogramming of tumors by regulating glycolytic and mitochondrial metabolism. This cluster is deregulated in B-cell lymphomas, B-cell chronic lymphocytic leukemia, acute myeloid leukemia, and T-cell lymphomas, and is particularly overexpressed in several other cancers. Based on the current knowledge, we can conclude that there is a large number of miRNAs present in mitochondria, termed mitomiR, and that they are important regulators of mitochondrial function. Therefore, mitomiRs are important players in the metabolism of cancer cells, which need to be further investigated in order to develop a potential new therapies for cancer.

Bioinformatics Analysis for Identifying Differentially Expressed MicroRNAs Derived from Plasma Exosomes Associated with Radiotherapy Resistance in Non-Small-Cell Lung Cancer

“…However, miRs are also involved in the occurrence and development of tumors and work in the form of clusters. Numerous studies have confirmed the miR-17-92 cluster as a major oncogenic driver or secondary event that enhances the oncogenic process in different cancer types [ 16 , 17 ]. Lee et al [ 18 ] confirmed that the overexpression of miR-7 could enhance the radiotherapy sensitivity of malignant glioma and breast cancer cells.…”

Implication of microRNAs in Carcinogenesis with Emphasis on Hematological Malignancies and Clinical Translation

“…According to the latest data, impaired expression of miR-652-5p leads to decreased levels of ATP, lactate, and pyruvate in T-ALL cell lines, thereby providing a potential drug target [ 79 ]. A special subgroup of miRNAs, so-called mitomiRs, are localized in the mitochondria and play an essential role in the control of cancer cell metabolism by targeting key transporters, metabolic enzymes and several oncogenic pathways [ 80 ]. Expression levels of metabolism-regulating miRNAs in leukemic stem and progenitor cells have to be further evaluated.…”

Roles of Mitochondria in Oral Squamous Cell Carcinoma Therapy: Friend or Foe?

“…Mitochondrial microRNAs (mitomiRs), which originate in the nucleus or from mtDNA, are microRNAs located in the mitochondria that play a crucial role in the regulation of mitochondrial function [ 137 ].…”